Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERA: Liporaxel vs IV Paclitaxel in Metastatic Breast Cancer
NCT03326102Phase 2Completed
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Start
- Jul 2018
- Primary completion
- Dec 2022
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of paclitaxel oral solution in breast cancer, sponsored by Daehwa Pharmaceutical Co., Ltd.. Started Jul 2018; status: completed.
02
Drugs
paclitaxel oral solution
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03326102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326102.